COVID-19 in Childhood: Transmission, Clinical Presentation, Complications and Risk Factors

Abstract

Children less than 18 years of age account for an estimated 500,000 to 1.5 million global SARS-CoV-2 cases. Lower prevalence of COVID-19 among children, in addition to higher numbers of mild and asymptomatic cases, continues to provide challenges in determining appropriate prevention and treatment courses. Here, we summarize the current evidence on the transmission, clinical presentation, complications and risk factors in regards to SARS-CoV-2 in children and highlight crucial gaps in knowledge going forward. Based on current evidence, children are rarely the primary source of secondary transmission in the household or in child care and school settings and are more likely to contract the virus from an adult household member. Higher transmission rates are observed in older children (10-19 years old) compared to younger children (<10 years old). While increasing incidence of COVID-19 in neonates raises the suspicion of vertical transmission, it is unlikely that breast milk is a vehicle for transmission from mother to infant. The vast majority of clinical cases of COVID-19 in children are mild, but there are rare cases that have developed complications such as multisystem inflammatory syndrome in children (MIS-C), which often presents with severe cardiac symptoms requiring intensive care. Childhood obesity is associated with a higher risk of infection and a more severe clinical presentation. Although immediate mortality rates among children are low, long-term respiratory and developmental implications of the disease remain unknown in this young and vulnerable population.

Clinical features and characteristics of pediatric patients with COVID-19 infection: Experiences in a Tertiary Taiwan Hospital

“…This study revealed more than half patients were household transmission. This finding is consistent with several observational studies [22,37–40] and literature reviews [41] which pointed out children are more likely to contract virus from adult household members. Moreover, the clinical features of the disease were mild in this study and almost one-half patients were asymptomatic.…”

Off-Label Prescription of COVID-19 Vaccines in Children: Clinical, Ethical, and Legal Issues

“…While obesity has been consistently associated with risk of severe disease, findings regarding other comorbidities have been inconsistent. 20 Kompaniyetes et al, for example, did not include a category of chronic lung disease and did not find an association between asthma or neurodevelopmental disorders and severe illness. 9 As for the risk of complications from the vaccine, information about children less than 12 years is forthcoming.…”

Network analysis of England's single parent household COVID-19 control policy impact: a proof-of-concept study

“…As a proof-of-concept study, this work also did not take account of all variables likely to affect household transmission and worked under certain hypotheses concerning family size and constitution. For example, distribution of offspring age was not accounted for, although younger children are less likely to transmit COVID-19 [19] while older children are more likely to lose contact with their fathers, which would reduce OHL. In the absence of available data, we were not able to account for variation in the amount of time that a child spent with each parent, or the frequency of movement between households.…”